InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: Rogerthat1 post# 9202

Tuesday, 05/31/2016 6:55:36 PM

Tuesday, May 31, 2016 6:55:36 PM

Post# of 16893
I agree. I assumed the "rebate" would just be some formula negotiated with the insurance companies based on cost and the level of insurance the patient had paid for. Braeburn's "value based" formula actually provides an incentive for insurance companies to allow probuphine coverage. If you end up paying more, says Braeburn, we will refund you the money.

If probuphine works as well as it has in clinical trials, there will be many fewer emergency room visits, accidental overdoses or ingestions and detox and rehab stays. Which will save insurance companies and hospitals money...far more money than they will pay for the full price of probuphine ($4,950 a treatment).


That is pretty unique, and at least to me, pretty compelling.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News